These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 29226707

  • 1. Managing anticoagulation in patients receiving implantable cardiac devices.
    Chousou PA, Pugh PJ.
    Future Cardiol; 2018 Mar; 14(2):151-164. PubMed ID: 29226707
    [Abstract] [Full Text] [Related]

  • 2. Managing anticoagulation in patients receiving implantable cardiac devices.
    Mangrolia N, Nayar V, Pugh PJ.
    Future Cardiol; 2012 May; 8(3):393-411. PubMed ID: 26203472
    [Abstract] [Full Text] [Related]

  • 3. Management of Perioperative Anticoagulation for Device Implantation.
    Stewart MH, Morin DP.
    Card Electrophysiol Clin; 2018 Mar; 10(1):99-109. PubMed ID: 29428146
    [Abstract] [Full Text] [Related]

  • 4. Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation.
    Tompkins C, Henrikson CA.
    Cardiol J; 2011 Mar; 18(1):103-9. PubMed ID: 21305497
    [Abstract] [Full Text] [Related]

  • 5. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
    Du L, Zhang Y, Wang W, Hou Y.
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
    [Abstract] [Full Text] [Related]

  • 6. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
    Jamula E, Douketis JD, Schulman S.
    J Thromb Haemost; 2008 Oct; 6(10):1615-21. PubMed ID: 18638011
    [Abstract] [Full Text] [Related]

  • 7. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
    Deharo JC, Sciaraffia E, Leclercq C, Amara W, Doering M, Bongiorni MG, Chen J, Dagres N, Estner H, Larsen TB, Johansen JB, Potpara TS, Proclemer A, Pison L, Brunet C, Blomström-Lundqvist C, Coordinated by the Scientific Initiatives Committee of the European Heart Rhythm Association.
    Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
    [Abstract] [Full Text] [Related]

  • 8. Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.
    Essebag V, Healey JS, Ayala-Paredes F, Kalfon E, Coutu B, Nery P, Verma A, Sapp J, Philippon F, Sandhu RK, Coyle D, Eikelboom J, Wells G, Birnie DH.
    Am Heart J; 2016 Mar; 173():102-7. PubMed ID: 26920602
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial.
    Leef GC, Hellkamp AS, Patel MR, Becker RC, Berkowitz SD, Breithardt G, Halperin JL, Hankey GJ, Hacke W, Nessel CC, Singer DE, Fox KAA, Mahaffey KW, Piccini JP.
    J Am Heart Assoc; 2017 Jun 14; 6(6):. PubMed ID: 28615214
    [Abstract] [Full Text] [Related]

  • 11. [Management of antithrombotic therapy in patients undergoing implantation or replacement of cardiac implantable electronic devices].
    Zacà V, Marcucci R, Parodi G, Limbruno U, Notarstefano P, Pieragnoli P, Di Cori A, Bongiorni MG, Casolo G.
    G Ital Cardiol (Rome); 2014 Jan 14; 15(1):56-72. PubMed ID: 24503736
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New oral anticoagulants and perioperative management of anticoagulant/antiplatelet agents.
    Rahman A, Latona J.
    Aust Fam Physician; 2014 Dec 14; 43(12):861-6. PubMed ID: 25705736
    [Abstract] [Full Text] [Related]

  • 15. Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey.
    Nascimento T, Birnie DH, Healey JS, Verma A, Joza J, Bernier ML, Essebag V.
    Can J Cardiol; 2014 Feb 14; 30(2):231-6. PubMed ID: 24461924
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
    Cano O, Muñoz B, Tejada D, Osca J, Sancho-Tello MJ, Olagüe J, Castro JE, Salvador A.
    Heart Rhythm; 2012 Mar 14; 9(3):361-7. PubMed ID: 22001709
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
    Ahmed I, Gertner E, Nelson WB, House CM, Dahiya R, Anderson CP, Benditt DG, Zhu DW.
    Heart Rhythm; 2010 Jun 14; 7(6):745-9. PubMed ID: 20176137
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.